OPVEE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Opvee, and what generic alternatives are available?
Opvee is a drug marketed by Indivior and is included in one NDA. There is one patent protecting this drug.
This drug has eleven patent family members in eight countries.
The generic ingredient in OPVEE is nalmefene hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalmefene hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opvee
A generic version of OPVEE was approved as nalmefene hydrochloride by PURDUE PHARMA LP on February 8th, 2022.
Summary for OPVEE
International Patents: | 11 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OPVEE |
What excipients (inactive ingredients) are in OPVEE? | OPVEE excipients list |
DailyMed Link: | OPVEE at DailyMed |
Pharmacology for OPVEE
Drug Class | Opioid Antagonist |
Mechanism of Action | Opioid Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for OPVEE
US Patents and Regulatory Information for OPVEE
OPVEE is protected by one US patents and one FDA Regulatory Exclusivity.
Patents protecting OPVEE
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATING OPIOID OVERDOSE
FDA Regulatory Exclusivity protecting OPVEE
NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indivior | OPVEE | nalmefene hydrochloride | SPRAY;NASAL | 217470-001 | May 22, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Indivior | OPVEE | nalmefene hydrochloride | SPRAY;NASAL | 217470-001 | May 22, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OPVEE
See the table below for patents covering OPVEE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 3044221 | COMPOSITIONS ET METHODES DE TRAITEMENT D'UNE PRISE EXCESSIVE D'OPIOIDES (COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSE) | ⤷ Try a Trial |
Japan | 2023140359 | オピオイド過剰摂取を処置するための組成物および方法 (COMPOSITIONS AND METHODS FOR TREATMENT OF OPIOID OVERDOSE) | ⤷ Try a Trial |
Russian Federation | 2019118465 | КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ ПЕРЕДОЗИРОВКИ ОПИОИДАМИ | ⤷ Try a Trial |
European Patent Office | 3541386 | COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'UNE PRISE EXCESSIVE D'OPIOÏDES (COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSE) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2018093666 | ⤷ Try a Trial | |
Russian Federation | 2769397 | КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ ПЕРЕДОЗИРОВКИ ОПИОИДАМИ (COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE) | ⤷ Try a Trial |
China | 110139651 | 用于治疗阿片样物质过量的组合物和方法 (COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPIOID OVERDOSE) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |